This information is the total number of products in Research and Development (R&D) per disease as reported by PhRMA and gives the number of products in phase III.
Last New Drug Approval
This information comes from the official community register of new medicines. Data collection started in January 2011.
The epidemiological indicators are multiple, from the most recent public sources and allow the comparison between diseases and countries
This information allows you to zoom in on country epidemiological and burden of disease data and provides an instant view on the selected country from the map
About this disease
About this disease gives a short summary of each disease Data selection details the source and limits of the information Other information shows the World Disease days and the latest policy evolution around each disease
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.